Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function.
from The Medical News http://ift.tt/1D3f3cu
from The Medical News http://ift.tt/1D3f3cu
No comments:
Post a Comment